Are you Dr. Shoamanesh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Boston Medical Ctr Pl
Boston, MA 02118Phone+1 617-638-8000
Certifications & Licensure
MA State Medical License 2012 - 2013
Clinical Trials
- NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH Start of enrollment: 2017 Apr 26
- EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) Start of enrollment: 2019 Sep 20
Publications & Presentations
PubMed
- 9 citationsAnticoagulation in patients with cerebral amyloid angiopathy.Ashkan Shoamanesh,
Lancet. 2023-10-21 - 4 citationsAssociation Between Hematoma Expansion Severity and Outcome and Its Interaction With Baseline Intracerebral Hemorrhage Volume.Andrea Morotti, Gregoire Boulouis, Jawed Nawabi, Qi Li, Andreas Charidimou
Neurology. 2023-10-17 - 78 citationsFactor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, ...Ashkan Shoamanesh, Hardi Mundl, Eric E Smith, Jaime Masjuan, Ivan Milanov
Lancet. 2022-09-24
Press Mentions
Exploratory Analysis of PACIFIC-Stroke Trial Suggests Asundexian May Prevent Recurrent Ischemic Stroke Without Increased BleedingAugust 28th, 2022
Cerebral Microbleeds and Risk of Intracerebral Hemorrhage After StrokeSeptember 29th, 2016- Inflammatory Biomarkers May Help Predict, Prevent StrokeAugust 25th, 2016
- Join now to see all
